India Immunology Drugs Market to grow at a formidable rate During the Forecast Period
Increasing incidence of immunological
diseases is expected to drive the growth of India immunology drugs market
during the forecast period.
According
to TechSci Research report, “India Immunology Drugs Market By Drug Class
(Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine
therapies, Immunosuppressive medication, Others), By Indication (Arthritis,
Plaque Psoriasis, Spondylitis, Inflammatory Bowel Disease, Transplant
Rejection, Others), By Application (Hospitals, Clinics, Cancer Research
Institute, Others), By Company, By Region, Forecast & Opportunities, FY2026”, the India immunology drugs market is expected to grow at a
formidable rate during the forecast period on account of surging drug research
and development. Rising prevalence of chronic ailments such as spondylitis,
inflammatory bowel disease, arthritis in the country is bolstering the demand
for immunological drugs and medications. In addition to this, growing adoption
of immunosuppressants in the market coupled with continuous upgradation of
existing product portfolio by key market players are further expected to fuel
the market growth through FY2026. Also, rising trend of patent expiry is
estimated to drive the demand for such drugs. However, regulatory barriers on
biosimilars and the increase in drug pricing can restrict the market growth
over the next few years. Moreover, stringent FDA regulations can further hinder
the market growth during the forecast period.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " India Immunology Drugs Market"
https://www.techsciresearch.com/report/india-immunology-drugs-market/7240.html
The India immunology drugs market is segmented based on drug class, indication,
application, company, and region. Based on indication, the market can be
fragmented into arthritis, plaque psoriasis, spondylitis, inflammatory bowel
disease, transplant rejection, others. The arthritis segment is expected to
dominate the market in the forthcoming years on account of increased count of
population having arthritis. Moreover, high efficiency of immunological drugs
in treating arthritis is further influencing the segmental growth in the
upcoming years. Based on application, the market can be categorized into hospitals,
clinics, cancer research institute, others. The hospitals segment dominated the
market until FY2020 owing to increased patient pool in hospitals. Also,
increasing number of surgeries along with well-established equipments for
carrying out procedures in hospitals is further expected to drive segmental
growth in the years to come.
Panacea Biotec Ltd., Bristol Myers
Squibb India Pvt. Ltd., Wockhardt Ltd., Pfizer Limited, Sanofi India Ltd.,
GlaxoSmithKline Pharmaceuticals Ltd., Abbott India Ltd., Genentech (Roche)
India Pvt. Ltd., Novartis India Ltd., Allergan India Private Limited and others are some of the leading players operating in India Immunology
drugs market. Companies operating in the market are using organic strategies
such as product launches, mergers, and collaborations to boost their share and
increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7240
Customers can also
request for 10% free customization on this report.
“India immunology drugs market is
expected to witness high growth during the forecast period which is
attributable to introduction of new and sophisticated targeted therapies.
Additionally, major market players are focusing on strategic collaborations to
commercialize their newly developed drugs. This is further expected to create
lucrative opportunities for the market growth of India immunology drugs market over
the next five years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Immunology Drugs Market By Drug Class
(Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine
therapies, Immunosuppressive medication, Others), By Indication (Arthritis,
Plaque Psoriasis, Spondylitis, Inflammatory Bowel Disease, Transplant
Rejection, Others), By Application (Hospitals, Clinics, Cancer Research
Institute, Others), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India immunology
drugs market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India immunology drugs market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]